Prior Auth Required

81170 - ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib
Procedure / Service Description

Genetic and Molecular Testing Medical Necessity Guideline - 81168 CCND1/IGH (t(11;14)) (eg, mantle cell lymphoma) translocation analysis, major breakpoint, qualitative and quantitative, if performed 81170 ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domain 81171 AFF2 (ALF transcription elongation factor 2 [FMR2]) (eg, fragile X intellectual

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.